Principles and basis for selecting treatment methods for small and medium-sized vestibular schwannoma

doi:10.3877/cma.j.issn.2095-123X.2024.01.001

Abstract

Abstract:

There are various treatment strategies for small and medium-sized vestibular schwannoma (VS), including microsurgery (MS), stereotactic radiosurgery surgery (SRS), and conservative treatment (CT). The three treatment plans have similar results in tumor control and facial nerve function, providing good results in disease control and complications, with the main difference being the protection of hearing. At present, the optimal treatment method for small and medium-sized VS is still controversial, especially for young patients with normal hearing, the necessity of treatment, and the optimal timing for hearing protection. In clinical practice, it is necessary to choose the treatment mode individually and reasonably. This article summarizes and analyzes the advantages and disadvantages of three treatment modes, aiming to achieve long-term functional preservation and improve the quality of life of patients.

Key words: Small and medium-sized vestibular schwannoma, Microsurgery, Stereotactic radiosurgery treatment, Conservative treatment, Hearing protection

Lihua Chen. Principles and basis for selecting treatment methods for small and medium-sized vestibular schwannoma[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2024, 14(01): 1-7.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnkjbykfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-123X.2024.01.001

https://zhnkjbykfzz.cma-cmc.com.cn/EN/Y2024/V14/I01/1

References 35

[1]	Zhu W, Chen H, Jia H, et al. Long-term hearing preservation outcomes for small vestibular schwannomas: retrosigmoid removal versus observation[J]. Otol Neurotol, 2018, 39(2): e158-e165. DOI: 10.1097/mao.0000000000001684.
[2]	Marinelli JP, Lees KA, Lohse CM, et al. Natural history of growing sporadic vestibular schwannomas: an argument for continued observation despite documented growth in select cases[J]. Otol Neurotol, 2020, 41(9): e1149-e1153. DOI: 10.1097/mao.0000000000002756.
[3]	Olson JJ, Kalkanis SN, Ryken TC. Congress of neurological surgeons systematic review and evidence-based guidelines on the treatment of adults with vestibular schwannomas: executive summary[J]. Neurosurgery, 2018, 82(2): 129-134. DOI: 10.1093/neuros/nyx586.
[4]	Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma[J]. J Clin Neurosci, 2016, 32: 1-8. DOI: 10.1016/j.jocn.2016.05.003.
[5]	Huo Z, Chen J, Wang Z, et al. Prognostic factors of long-term hearing preservation in small and medium-sized vestibular schwannomas after microsurgery[J]. Otol Neurotol, 2019, 40(7): 957-964. DOI: 10.1097/mao.0000000000002284.
[6]	Kirchmann M, Karnov K, Hansen S, et al. Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma[J]. Neurosurgery, 2017, 80(1): 49-56. DOI: 10.1227/neu.0000000000001414.
[7]	Carlson ML, Link MJ, Wanna GB, et al. Management of sporadic vestibular schwannoma[J]. Otolaryngol Clin North Am, 2015, 48(3): 407-422. DOI: 10.1016/j.otc.2015.02.003.
[8]	Peng KA, Wilkinson EP. Optimal outcomes for hearing preservation in the management of small vestibular schwannomas[J]. J Laryngol Otol, 2016, 130(7): 606-610. DOI: 10.1017/s0022215116007969.
[9]	Charabi S, Thomsen J, Tos M, et al. Acoustic neuroma/vestibular schwannoma growth: past, present and future[J]. Acta Otolaryngol, 1998, 118(3): 327-332. DOI: 10.1080/00016489850183395.
[10]	Deberge S, Meyer A, Le Pabic E, et al. Quality of life in the management of small vestibular schwannomas: observation, radiotherapy and microsurgery[J]. Clin Otolaryngol, 2018, 43(6): 1478-1486. DOI: 10.1111/coa.13203.
[11]	Carlson ML, Barnes JH, Nassiri A, et al. Prospective study of disease-specific quality-of-life in sporadic vestibular schwannoma comparing observation, radiosurgery, and microsurgery[J]. Otol Neurotol, 2021, 42(2): e199-e208. DOI: 10.1097/mao.0000000000002863.
[12]	Zanoletti E, Cazzador D, Faccioli C, et al. Multi-option therapy vs observation for small acoustic neuroma: hearing-focused management[J]. Acta Otorhinolaryngol Ital, 2018, 38(4): 384-392. DOI: 10.14639/0392-100x-1756.
[13]	Kiyofuji S, Neff BA, Carlson ML, et al. Large and small vestibular schwannomas: same, yet different tumors[J]. Acta Neurochir (Wien), 2021, 163(8): 2199-2207. DOI: 10.1007/s00701-021-04705-6.
[14]	Lees KA, Tombers NM, Link MJ, et al. Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth[J]. Otolaryngol Head Neck Surg, 2018, 159(3): 535-542. DOI: 10.1177/0194599818770413.
[15]	Patnaik U, Prasad SC, Tutar H, et al. The long-term outcomes of wait-and-scan and the role of radiotherapy in the management of vestibular schwannomas[J]. Otol Neurotol, 2015, 36(4): 638-646. DOI: 10.1097/mao.0000000000000657.
[16]	Massick DD, Welling DB, Dodson EE, et al. Tumor growth and audiometric change in vestibular schwannomas managed conservatively[J]. Laryngoscope, 2000, 110(11): 1843-1849. DOI: 10.1097/00005537-200011000-00015.
[17]	Patel NS, Huang AE, Dowling EM, et al. The influence of vestibular schwannoma tumor volume and growth on hearing loss[J]. Otolaryngol Head Neck Surg, 2020, 162(4): 530-537. DOI: 10.1177/0194599819900396.
[18]	Hughes M, Skilbeck C, Saeed S, et al. Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome[J]. Skull Base, 2011, 21(5): 295-302. DOI: 10.1055/s-0031-1284219.
[19]	Moffat DA, Kasbekar A, Axon PR, et al. Growth characteristics of vestibular schwannomas[J]. Otol Neurotol, 2012, 33(6): 1053-1058. DOI: 10.1097/MAO.0b013e3182595454.
[20]	Fayad JN, Semaan MT, Lin J, et al. Conservative management of vestibular schwannoma: expectations based on the length of the observation period[J]. Otol Neurotol, 2014, 35: 1258-1265. DOI: 10.1097/MAO.0000000000000285.
[21]	Sughrue ME, Yang I, Aranda D, et al. The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes[J]. J Neurosurg, 2010, 112(1): 163-167. DOI: 10.3171/2009.4.Jns08895.
[22]	Varughese JK, Breivik CN, Wentzel-Larsen T, et al. Growth of untreated vestibular schwannoma: a prospective study[J]. J Neurosurg, 2012, 116(4): 706-712. DOI: 10.3171/2011.12.Jns111662.
[23]	Charabi S, Thomsen J, Mantoni M, et al. Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy[J]. Otolaryngol Head Neck Surg, 1995, 113(1): 5-14. DOI: 10.1016/s0194-59989570138-9.
[24]	Golfinos JG, Hill TC, Rokosh R, et al. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas[J]. J Neurosurg, 2016, 125(6): 1472-1482. DOI: 10.3171/2015.12.Jns151857.
[25]	Schwartz MS, Lekovic GP, Miller ME, et al. Translabyrinthine microsurgical resection of small vestibular schwannomas[J]. J Neurosurg, 2018, 129(1): 128-136. DOI: 10.3171/2017.2.Jns162287.
[26]	Scheich M, Ehrmann-Müller D, Shehata-Dieler W, et al. Hearing results after middle fossa removal of small (T1/T2) vestibular schwannomas[J]. HNO, 2017, 65(9): 751-757. DOI: 10.1007/s00106-016-0228-5.
[27]	Mazzoni A, Zanoletti E, Denaro L, et al. Retrolabyrinthine meatotomy as part of retrosigmoid approach to expose the whole internal auditory canal: rationale, technique, and outcome in hearing preservation surgery for vestibular schwannoma[J]. Oper Neurosurg (Hagerstown), 2018, 14(1): 36-44. DOI: 10.1093/ons/opx091.
[28]	Zanoletti E, Mazzoni A, d'Avella D. Hearing preservation in small acoustic neuroma: observation or active therapy? Literature review and institutional experience[J]. Acta Neurochir (Wien), 2019, 161(1): 79-83. DOI: 10.1007/s00701-018-3739-x.
[29]	Mazzoni A, Zanoletti E, Calabrese V. Hearing preservation surgery in acoustic neuroma: long-term results[J]. Acta Otorhinolaryngol Ital, 2012, 32(2): 98-102.
[30]	Carlson ML, Vivas EX, McCracken DJ, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas[J]. Neurosurgery, 2018, 82(2): E35-E39. DOI: 10.1093/neuros/nyx511.
[31]	Han MS, Jung S, Lim SH, et al. What clinicians should consider to determine a more beneficial treatment strategy for small to medium sized vestibular schwannoma with serviceable hearing: a single surgeon's long-term outcome of microsurgery and gamma knife radiosurgery[J]. Otol Neurotol, 2020, 41(8): 1122-1130. DOI: 10.1097/mao.0000000000002721.
[32]	Mastronardi L, Di Scipio E, Cacciotti G, et al. Hearing preservation after removal of small vestibular schwannomas by retrosigmoid approach: comparison of two different ABR neuromonitoring techniques[J]. Acta Neurochir (Wien), 2019, 161(1): 69-78. DOI: 10.1007/s00701-018-3740-4.
[33]	Carlson ML, Tveiten ØV, Lund-Johansen M, et al. Patient motivation and long-term satisfaction with treatment choice in vestibular schwannoma[J]. World Neurosurg, 2018, 114: e1245-e1252. DOI: 10.1016/j.wneu.2018.03.182.
[34]	Link MJ, Lund-Johansen M, Lohse CM, et al. Quality of life in patients with vestibular schwannomas following gross total or less than gross total microsurgical resection: Should we be taking the entire tumor out?[J]. Neurosurgery, 2018, 82(4): 541-547. DOI: 10.1093/neuros/nyx245.
[35]	Macielak RJ, Thao V, Borah BJ, et al. Lifetime cost and quality-adjusted life-years across management options for small- and medium-sized sporadic vestibular schwannoma[J]. Otol Neurotol, 2021, 42(9): e1369-e1375. DOI: 10.1097/mao.0000000000003266.

Please choose a citation manager

Content to export